Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
2020 · Nature · 4,433 citations
https://doi.org/10.1038/s41586-020-2223-y
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
141
Papers
7.7K
Citations
28
h-index
59
i10-index
Lin Wang is an academic researcher from Children's Hospital of Capital Institute of Pediatrics. The author has contributed to research in topics: Computational Drug Discovery Methods & PI3K/AKT/mTOR signaling in cancer & Antibiotic Resistance in Bacteria. The author has an h-index of 28, co-authored 120 publications.
ORCID: 0000-0003-2482-7638Papers by this author
worksA robust, single-injection method for targeted, broad-spectrum plasma metabolomics
2017 · Metabolomics · 62 citations
https://doi.org/10.1007/s11306-017-1264-1
Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with β-lactam antibiotics against MRSA
2022 · Frontiers in Microbiology · 28 citations
https://doi.org/10.3389/fmicb.2022.993430
Artificial Intelligence–Assisted Bone Age Assessment to Improve the Accuracy and Consistency of Physicians With Different Levels of Experience
2022 · Frontiers in Pediatrics · 23 citations
https://doi.org/10.3389/fped.2022.818061
Conformational Space Profiling Enhances Generic Molecular Representation for AI‐Powered Ligand‐Based Drug Discovery
2024 · Advanced Science · 21 citations
https://doi.org/10.1002/advs.202403998
Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder
2024 · Communications Biology · 15 citations
https://doi.org/10.1038/s42003-024-06102-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat